We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medicover Ab | LSE:0RPS | London | Ordinary Share | SE0009778848 | MEDICOVER ORD SHS CLASS B |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 81.20 | 79.20 | 83.20 | 682 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 1.75B | 17.6M | 0.2412 | 336.65 | 5.93B |
STOCKHOLM, Feb. 14, 2020 /PRNewswire/ -- Fourth Quarter
Full Year
REVENUE AND EARNINGS
€ millions (€m) | Q4 2019 | Q4 2018 | Growth | FY 2019 | FY 2018 | Growth |
Revenue | 229.7 | 181.2 | 27% | 844.4 | 671.6 | 26% |
Operating profit (EBIT) | 10.8 | 8.6 | 27% | 46.5 | 33.7 | 38% |
Operating profit margin, % | 4.7% | 4.7% | 5.5% | 5.0% | ||
Net profit | 6.6 | 3.5 | 91% | 24.7 | 24.2 | 2% |
Net profit margin, % | 2.9% | 1.9% | 2.9% | 3.6% | ||
Basic/diluted earnings per share, € | 0.048 | 0.022 | 118% | 0.168 | 0.167 | 1% |
EBITDA | 33.4 | 24.3 | 37% | 120.7 | 90.7 | 33% |
EBITDA margin, % | 14.5% | 13.4% | 14.3% | 13.5% | ||
EBITDAaL | 22.3 | 15.9 | 40% | 80.6 | 58.5 | 38% |
EBITDAaL margin, % | 9.7% | 8.8% | 9.5% | 8.7% | ||
EBITA | 13.9 | 10.0 | 39% | 53.7 | 37.0 | 45% |
EBITA margin, % | 6.0% | 5.5% | 6.4% | 5.5% |
For definition and reconciliation of alternative performance measures, refer to note 10. As from Q3 2019 margins (including margins of comparative figures) and growth rates have been calculated based on EUR whole figures instead of figures rounded in millions.
This is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact person set out below at 7.45 (CET) on 14 February 2020. This interim report and other information about Medicover is available at medicover.com.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenue around €672 million and 20,970 employees. For more information, go to www.medicover.com
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
Phone: +46-70-303-3272
hanna.bjellquist@medicover.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medicover/r/year-end-report-january-december-2019,c3035280
The following files are available for download:
https://mb.cision.com/Main/15662/3035280/1193827.pdf | Year-end report January-December 2019 |
Copyright 2020 PR Newswire
1 Year Medicover Ab Chart |
1 Month Medicover Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions